オンコロジー(腫瘍)バイオマーカーの世界市場は、2022年に155億ドルに達し、2023年までに176億ドル、2028年までに352億ドルに拡大し、予測期間中のCAGRは14.9%と推定されます。
目次
Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology and Information Sources
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter- 2: Summary and Highlights
Table Summary : Global Market for Oncology Biomarkers, by Biomarker Type, Through 2028
Figure Summary : Global Market for Oncology Biomarkers, by Biomarker Type, 2020-2028
Chapter- 3: Market Outlook
Chapter- 4: Market and Technology Background
Overview of Biomarkers
Classification of Biomarkers
Types of Biomarkers
Biomarker Discovery, Verification and Validation
Overview of Cancer
Cancer/Oncology Biomarkers
Oncology Biomarkers Testing Methods
Oncology Biomarkers Testing Types
Biomarker Test Development and Marketing
Chapter- 5: Market Dynamics
Drivers
Barriers
Chapter- 6: Market Breakdown by Biomarker Type
Protein Biomarkers
Genomic Biomarker
Other Biomarkers
Global Market for Oncology Biomarkers, by Biomarker Type
Chapter- 7: Market Breakdown by Application
Life Science Research
Risk Assessment and Screening
Diagnostics
Prognostics
Therapeutic Selection and Clinical Trials
Monitoring
Global Market for Oncology Biomarkers by Application
Chapter- 8: Market Breakdown by Cancer Type
Market Overview
Breast Cancer
Lung Cancer
Colorectal Cancer (CRC)
Prostate Cancer
Bladder Cancer
Melanoma
Leukemia
Others
Global Market for Oncology Biomarkers by Cancer Type
Chapter- 9: Market Breakdown by Region
Global Market for Oncology Biomarkers by Region
North America
Europe
Asia-Pacific
Rest of World
Chapter- 10: Impact of COVID-19
Overview
Implications on Cancer Diagnosis
Implications on Cancer Treatment
Impact on Oncology Biomarkers Market
Chapter- 11: Emerging Trends and Technologies in the Market
Emerging Technologies and Trends in the Market
Liquid Biopsy
Circulating Free Nucleic Acids
"Organ Agnostic" Biomarker Testing
Blood Test for Early-Stage Cancer Detection
Chapter- 12: Competitive Landscape
Overview
Mergers and Acquisitions
SWOT Analysis for Global Oncology Biomarker Market
Porter's Five Forces Analysis of Global Oncology Biomarker Market
Chapter- 13: Company Profiles
AGENDIA INC.
ABBOTT
AGILENT TECHNOLOGIES INC.
BIOCARTIS NV
BIOMERIEUX S.A.
BIO-RAD LABORATORIES INC.
BECTON, DICKINSON & CO.
EXACT SCIENCES CORP.
F. HOFFMANN-LA ROCHE AG
GUARDANT HEALTH INC.
HOLOGIC INC.
ILLUMINA INC.
LEICA BIOSYSTEMS
MERCK KGAA
MYRIAD GENETICS INC.
QIAGEN N.V.
SIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
VERACYTE INC.
Chapter- 14: Appendix: Acronyms
Table 80 : Abbreviations Used in This Report